Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial

被引：0
|
作者：
Khan, S. [1 ]
Butler, J. [2 ]
Young, R. [1 ]
Lewis, B. S. [3 ]
Escobedo, J. [4 ]
Refsgaard, J. [5 ]
Reyes, E. [6 ]
Roessig, L. [7 ]
Blaustein, R. O. [8 ]
Lam, C. S. P. [9 ]
Voors, A. A. [10 ]
Ponikowski, P. [11 ]
Anstrom, K. J. [1 ]
Armstrong, P. [12 ]
机构：
[1] Duke Clin Res Inst, Durham, NC USA
[2] Baylor Univ, Med Ctr, Dallas, TX USA
[3] Lady Davis Carmel Med Ctr, Haifa, Israel
[4] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico
[5] Reg Hosp Viborg, Viborg, Denmark
[6] Philippine Gen Hosp, Manila, Philippines
[7] Bayer AG, Wuppertal, Germany
[8] Merck & Co Inc, Rahway, NJ USA
[9] Duke Natl Univ Singapore, Natl Heart Ctr Singapore, Singapore, Singapore
[10] Univ Med Ctr Groningen, Groningen, Netherlands
[11] Wroclaw Med Univ, Wroclaw, Poland
[12] Univ Alberta, Edmonton, AB, Canada
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes Insights From the EXSCEL Trial
    Fudim, Marat
    White, Jennifer
    Pagidipati, Neha J.
    Lokhnygina, Yuliya
    Wainstein, Julio
    Murin, Jan
    Iqbal, Nayyar
    Ohman, Peter
    Lopes, Renato D.
    Reicher, Barry
    Holman, Rury R.
    Hernandez, Adrian F.
    Mentz, Robert J.
    CIRCULATION, 2019, 140 (20) : 1613 - 1622
  • [22] Relationship Between Baseline Electrocardiographic Parameters and Outcomes in Patients With High-Risk Heart Failure With Reduced Ejection Fraction: Insights From the Vericiguat Global Study in Patients With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial
    Yogasundaram, Haran
    Zheng, Yinggan
    Ly, Eric
    Ezekowitz, Justin A.
    OConnor, Christopher M.
    Blaustein, Robert O.
    Roessig, Lothar
    Temple, Tracy C.
    Westerhout, Cynthia M.
    Armstrong, Paul W.
    Sandhu, Roopinder
    CIRCULATION, 2022, 146
  • [23] Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
    Petrie, Mark C.
    Verma, Subodh
    Docherty, Kieran F.
    Inzucchi, Silvio E.
    Anand, Inder
    Belohlavek, Jan
    Boehm, Michael
    Chiang, Chern-En
    Chopra, Vijay K.
    de Boer, Rudolf A.
    Desai, Akshay S.
    Diez, Mirta
    Drozdz, Jaroslaw
    Dukat, Andre
    Ge, Junbo
    Howlett, Jonathan
    Katova, Tzvetana
    Kitakaze, Masafumi
    Ljungman, Charlotta E. A.
    Merkely, Bela
    Nicolau, Jose C.
    O'Meara, Eileen
    Vinh, Pham Nguyen
    Schou, Morten
    Tereshchenko, Sergey
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Johanson, Per
    Greasley, Peter J.
    Boulton, David
    Bengtsson, Olof
    Jhund, Pardeep S.
    McMurray, John J. V.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14): : 1353 - 1368
  • [24] Vericiguat in worsening heart failure: agonising over, or celebrating, agonism in the VICTORIA trial
    Lang, Ninian N.
    Dobbin, Stephen J. H.
    Petrie, Mark C.
    CARDIOVASCULAR RESEARCH, 2020, 116 (12) : E152 - E155
  • [25] Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA)
    Ezekowitz, Justin A.
    Zheng, Yinggan
    Cohen-Solal, Alain
    Melenovsky, Vojtech
    Escobedo, Jorge
    Butler, Javed
    Hernandez, Adrian F.
    Lam, Carolyn S. P.
    O'Connor, Christopher M.
    Pieske, Burkert
    Ponikowski, Piotr
    Voors, Adriaan A.
    deFilippi, Christopher
    Westerhout, Cynthia M.
    McMullan, Ciaran
    Roessig, Lothar
    Armstrong, Paul W.
    CIRCULATION, 2021, 144 (18) : 1489 - 1499
  • [26] Age, Sex, and Outcomes in Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial
    Pina, Ileana L.
    Zheng, Yinggan
    Bonderman, Diana
    Pouleur, Anne
    Saldariagga, Clara
    Pieske, Burkert
    Blaustein, Robert O.
    Nkulikiyinka, Richard
    Westerhout, Cynthia M.
    Armstrong, Paul W.
    Lam, Carolyn S.
    CIRCULATION, 2022, 146
  • [27] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial
    Branch, Kelley
    Dagenais, G.
    Avezum, A.
    Basile, J.
    Conget, I.
    Cushman, W. C.
    Jansky, P.
    Lakshmanan, M.
    Lanas, F.
    Leitner, L. A.
    Pais, P.
    Pogosova, N.
    Raubenheimer, P. J.
    Gerstein, H.
    Probstfield, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 158 - 159
  • [28] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
    Branch, Kelley R. H.
    Dagenais, Gilles R.
    Avezum, Alvaro
    Basile, Jan
    Conget, Ignacio
    Cushman, William C.
    Jansky, Petr
    Lakshmanan, Mark
    Lanas, Fernando
    Leiter, Lawrence A.
    Pais, Prem
    Pogosova, Nana
    Raubenheimer, Peter J.
    Ryden, Lars
    Shaw, Jonathan E.
    Sheu, Wayne H-H
    Temelkova-Kurktschiev, Theodora
    Bethel, M. Angelyn
    Gerstein, Hertzel C.
    Chinthanie, Ramasundarahettige
    Probstfield, Jeffrey L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1805 - 1812
  • [29] Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial
    Felker, G. Michael
    North, Rebecca
    Mulder, Hillary
    Jones, W. Schuyler
    Anstrom, Kevin J.
    Patel, Mahesh J.
    Butler, Javed
    Ezekowitz, Justin A.
    Lam, Carolyn S. p.
    O'connor, Christopher M.
    Roessig, Lothar
    Hernandez, Adrian F.
    Victoria Study Grp
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (08) : 1113 - 1120
  • [30] Vericiguat-new treatment option for patients with heart failure Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA)
    Bauersachs, J.
    Nitschmann, S.
    INTERNIST, 2020, 61 (09): : 989 - 991
12345